| Company Name: | Zoll Medical Corporation | | Ticker Symbol: | ZOLL | | | WWW Address: | www.zoll.com | | CEO: | Richard A. Packer | | No. of Employees: | 1,431 | | Common Issue Type: | CS | | Business Description: | The Company develops technologies and software that help clinicians, emergency medical services personnel and lay rescuers advance the practice of resuscitation.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 24.99 |  -0.14 | 23.95 | 26.07 | 25.27 | 25.29 | 24.66 | 87679 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 530.2 | 21.1 | 1.27 | 0.45 | 0.00 | 55.8 | 0.0 | 25.29 - 11.24 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 25.13 | $ | | PE Ratio - LTM | 55.8 | |
| Market Capitalisation | 530.2 | mil |
| Latest Shares Outstanding | 21.1 | mil |
| Earnings pS (EPS) | 0.45 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 0 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 21.0 | mil |
| Float as % of Shares Outstanding | 99.4 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 37.50 | % |
| Research & Devlopment (R&D) as % of Revenue | 9.50 | % |
| Gross Profit Margin | 57.5 | % |
| EBITDA Margin | 10.4 | % |
| Pre-Tax Profit Margin | 5.6 | % |
| Assets Turnover | 1.1 | % |
| Return on Assets (ROA) | 4.2 | % |
| Return on Equity (ROE) | 5.4 | % |
| Return on Capital Invested (ROCI) | 5.4 | % |
| Current Ratio | 2.8 | |
| Leverage Ratio (Assets/Equity) | 1.3 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 6.85 | $ |
| Cash pS | 2.28 | $ |
| Book-Value pS | 13.07 | $ |
| Tangible Book-Value pS | 9.82 | $ |
| Cash Flow pS | 1.57 | $ |
| Free Cash Flow pS | 0.53 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.92 | |
| Price/Tangible Book Ratio | 2.56 | |
| Price/Cash Flow | 16.0 | |
| Price/Free Cash Flow | 47.0 | |
| P/E as % of Industry Group | 191.0 | % |
| P/E as % of Sector Segment | 26.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.7 | 101 | 3,073 | 3,310 |
| 4 Weeks | 25.29 | 19.00 | 19.42 | 29.4 | 121 | 2,514 | 42,734 |
| 13 Weeks | 25.29 | 17.58 | 18.42 | 36.4 | 127 | 1,865 | 113,749 |
| 26 Weeks | 25.29 | 15.86 | 16.81 | 49.5 | 124 | 1,801 | 225,132 |
| 52 Weeks | 25.29 | 11.24 | 17.81 | 41.1 | 114 | 2,026 | 504,513 |
| YTD | 25.29 | 11.24 | - | 33.0 | 109 | 2,019 | 458,411 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 24.70 | 23.96 | 21.67 | 19.22 | 17.86 | 1.27 | 1.30 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 15.71 | 92.0 | 16.91 |
| Income | 22.89 | 21.5 | -4.20 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 6.83 | NA | 1.69 |
| R&D | 15.08 | NA | 14.66 |
| Normalized Inc. | 25.93 | NA | 16.01 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -3.2 | 2.1 | 28.6 |
| Earnings % | -59.2 | -61.7 | -59.2 |
| EPS % | -59.1 | -61.0 | -59.1 |
| EPS $ | -0.65 | -0.25 | -0.65 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 37.97 |
| Current Ratio | 2.6 |
| Quick Ratio (Acid Test) | 1.6 |
| Liquidity Ratio (Cash) | 0.67 |
| Receivables Turnover | 4.7 |
| Average Collection Period | 77 |
| Working Capital/Equity | 49.7 |
| Working Capital pS | 6.61 |
| Cash-Flow pS | 0.00 |
| Free Cash-Flow pS | 0.00 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 5.23 |
| Financial Leverage Ratio (Assets/Equity) | 1.3 |
| Debt Ratio | 23.7 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 0.0 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 2.61 |
| Tobin's Q Ratio | 1.44 |
| Current P/E Ratio - LTM | 55.80 |
| Enterprise Value (EV)/EBITDA | 48.09 |
| Enterprise Value (EV)/Free Cash Flow | 0.00 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 2.56 |
| Price/Book Ratio - LTM | 1.92 |
| Price/Cash Flow Ratio | 16.0 |
| Price/Free Cash Flow Ratio - LTM | 47.0 |
| Price/Sales Ratio | 1.38 |
| P/E Ratio (1 month ago) - LTM | 46.1 |
| P/E Ratio (26 weeks ago) - LTM | 18.7 |
| P/E Ratio (52 weeks ago) - LTM | 16.2 |
| 5-Y High P/E Ratio | 184.2 |
| 5-Y Low P/E Ratio | 19.2 |
| 5-Y Average P/E Ratio | 54.3 |
| Current P/E Ratio as % of 5-Y Average P/E | 103 |
| P/E as % of Industry Group | 191.0 |
| P/E as % of Sector Segment | 26.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 35.9 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 4.12 |
| Tangible Book Value pS - LTM | 9.82 |
| Book Value pS - LTM | 13.07 |
| Capital Invested pS | 13.30 |
| Cash pS - LTM | 2.28 |
| Cash Flow pS - LTM | 1.57 |
| Free Cash Flow pS - LTM | 0.53 |
| Earnings pS (EPS) | 0.45 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 0.00 |
| Free Cash Flow Margin 5YEAR AVG | -0.46 |
| Net Profit Margin | 2.5 |
| Net Profit Margin - 5YEAR AVRG. | 4.0 |
| Equity Productivity | 1.37 |
| Return on Equity (ROE) | 3.4 |
| Return on Equity (ROE) - 5YEAR AVRG. | 5.9 |
| Capital Invested Productivity | 1.37 |
| Return on Capital Invested (ROCI) | 3.4 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 5.9 |
| Assets Productivity | 1.10 |
| Return on Assets (ROA) | 2.6 |
| Return on Assets (ROA) - 5YEAR AVRG. | 4.6 |
| Gross Profit Margin | 57.5 |
| Gross Profit Margin - 5YEAR AVRG. | 59.6 |
| EBITDA Margin - LTM | 10.4 |
| EBIT Margin - LTM | 5.6 |
| Pre-Tax Profit Margin | 0.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 6.8 |
| Effective Tax Rate | 28.5 |
| Effective Tax Rate - 5YEAR AVRG. | 28.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 75 |
| Revenue per Employee | 0 |
| Net Income per Employee | 0 |
| Average Collection Period | 75 |
| Receivables Turnover | 4.7 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 18.1 |
| Accounts Payble/Sales | 5.20 |
| Assets/Revenue | 0.91 |
| Net Working Capital Turnover | 2.76 |
| Fixed Assets Turnover | 2.73 |
| Total Assets Turnover | 1.1 |
| Revenue per $ Cash | 7.54 |
| Revenue per $ Plant | 9.48 |
| Revenue per $ Common Equity | 1.37 |
| Revenue per $ Capital Invested | 1.37 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 39.6 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |